Capvizr
THE DEAL, AT A GLANCE

Sling Therapeutics

From the announcement
01What happenedSling Therapeutics raised $123M Series C, announced 2026-09-16From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
02Why it mattersSling Therapeutics' $123M Series C positions the company above most tracked Healthcare & Life Sciences rounds, with the round at the 72th percentile by size in a sector…From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗

Sling Therapeutics · Financing Record

Explore source-linked visual explanations for Sling Therapeutics. Unsupported claims are withheld while source review continues.

Record 12427 · Recorded date: 2026-09-16

What it does

Sling Therapeutics: illustrative category image
Illustrative image (biotech lab), not Sling Therapeutics's product · Stephane Lesbats (IFREMER, Pôle Images, Centre Bretagne - ZI / CC BY 4.0

Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.

Open record 12427 →

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime